Champions Oncology, Inc. (CSBR) key performance indicators and operating metrics (5 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization | 574K | FY2026-Q3 |
| Adjusted Earnings per Share, Basic (Non-GAAP) | 0.04 USD_per_share | FY2026-Q3 |
| Oncology Services Margin | 47.00 percent | FY2026-Q3 |
| Adjusted Earnings per Share, Diluted (Non-GAAP) | 0.06 USD_per_share | FY2026-Q2 |
| Oncology Revenue | 15M | FY2026-Q2 |
Back to CSBR overview · CSBR earnings · CSBR holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.